tiprankstipranks
Trending News
More News >
Tiziana Life Sciences (US) (TLSA)
NASDAQ:TLSA
US Market

Tiziana Life Sciences (TLSA) Income Statement

Compare
663 Followers

Tiziana Life Sciences Income Statement

Last quarter (Q2 2025), Tiziana Life Sciences's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, Tiziana Life Sciences's net income was £-5.63M. See Tiziana Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Operating Expenses
£ 15.79M£ 17.98M£ 14.59M£ 27.37M£ 28.03M
Depreciation and Amortization
£ 124.00K£ 96.00K£ 51.00K£ 141.00K£ 89.76K
EBITDA
£ -16.62M£ -17.14M£ -15.34M£ -26.34M£ -27.93M
Operating Income
£ -15.79M£ -17.98M£ -14.59M£ -27.37M£ -28.03M
Other Income/Expenses
£ -952.00K£ 742.00K£ -811.00K£ 717.00K£ -312.00K
Pretax Income
£ -16.75M£ -17.24M£ -15.40M£ -26.66M£ -28.34M
Net Income
£ -11.86M£ -17.69M£ -15.40M£ -23.42M£ -26.13M
Per Share Metrics
Basic EPS
£ -0.22£ -0.34£ -0.30£ -0.48£ -0.54
Diluted EPS
£ -0.22£ -0.34£ -0.30£ -0.48£ -0.54
Weighted Average Shares Outstanding
53.34M 50.76M 50.76M 48.97M 48.65M
Weighted Average Shares Outstanding (Diluted)
53.34M 50.76M 50.76M 48.97M 48.65M
Currency in GBP

Tiziana Life Sciences Earnings and Revenue History